Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israeli Private Tech Firms Raised Record $2.74 Billion in Third Quarter
Error: Contact form not found.
by Reuters and Algemeiner Staff
A high-tech park in Haifa, Israel. Photo: Zvi Roger / Wikimedia Commons.
Israeli private high-tech companies raised a record $2.74 billion in the third quarter, overcoming the coronavirus pandemic with a 24 percent increase from a year ago, the Israel Venture Capital Research Center and ZAG law firm said on Wednesday.
In the first nine months of the year, fundraising — mostly in later stage rounds — reached $7.5 billion, close to the amount raised in all of 2019.
“This quarter foreign investors allocated the highest amounts of all time,” said Shmulik Zysman, managing partner at ZAG. “The total capital invested by Israeli funds is also the highest ever.”
Life science firms stood out in the third quarter, as one in four deals was from this sector.
Early-stage companies have been affected by the pandemic, with investors focusing on later stage companies, he said. Less than $100 million was raised by 95 seed deals so far this year.
“There is still more than enough money at the Israeli dedicated venture capital funds, but their appetite for risks has declined,” said Marianna Shapira, IVC research director.
